PIONEER 1: Randomized clinical trial of the efficacy and safety of oral semaglutide monotherapy in comparison with placebo in patients with type 2 diabetes - Aroda, VR; Rosenstock, J; Terauchi, Y (Diabetes Care, 2019)
doi:10.2337/dc19-0749.